Currently the price is 6,33$, Humacyte Inc, with address at 2525 NC-54, DURHAM, North Carolina, 27713, United States, is a publicly traded company and its visible heads at the moment are Dale A. Sander (Treasurer & Chief Financial Officer), Heather Prichard (Chief Operating Officer). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 6,21$ moving between 5,87$ and 6,54$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
